Plain-English translation of NCT05724121 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This study is watching patients who take BTK inhibitors (a type of blood cancer medication) or venetoclax to see if and when heart rhythm problems develop. Researchers know that BTK inhibitors can sometimes cause dangerous irregular heartbeats, but there's no standard way yet to screen for or monitor these problems. By doing regular heart tests before and during treatment, the study hopes to catch heart rhythm changes early so doctors can help prevent serious complications.
Some blood cancer medications are known to increase the risk of irregular heartbeats and sudden cardiac death, but doctors don't have clear guidelines on how to check for and monitor these problems. This study will help establish the best way to catch heart rhythm changes early and protect patients taking this medication.
You likely qualify if…
You likely don't qualify if…
You would have heart tests (like EKGs and portable heart monitors) before starting your blood cancer medication and then regularly while you're taking it. The study compares patients just starting the medication, those already on it, and those taking a different medication that doesn't cause heart problems. You'll need to be available for follow-up visits and be willing to share information about your heart health and medication.
AI-generated summary from trial data · Jul 13, 2026 · Not medical advice
United States